anim
anim
anim
  • All Categories
  • E-Services
  • NahdiNahdi Global
  • FlashFlash Sales
  • NahdicareNahdicare Health center
  • Home
  • GIT Treatments
  • IBS & Colitis
  • Genuine  brands

    Genuine brands


  • Temperature Controlled

    Temperature Controlled


  • Secure Payment

    Secure Payment

About Product

Product Description:


Salofalk 4g/60ml enemas contain the active substance mesalazine:



  • An anti-inflammatory agent used to treat inflammatory bowel disease.

  • Salofalk 4g/60ml enemas are used for the treatment of:

  • inflammation of the large intestine (colon) and rectum (back passage) known by doctors as ulcerative colitis.

  • It may be used alone or, particularly in the acute phase, with corticosteroids.

  • Acute attacks of ulcerative colitis (a chronic inflammatory disease of the large bowel)


How To Use:


Adults and elderly:



  • In patients with symptoms of acute inflammation, the content of one enema bottle (60 g rectal suspension) is administered into the intestine as a clyster once daily at bedtime.


 Children and adolescents:



  • There is little experience and only limited documentation for an effect in children.


General instructions for use:



  • Salofalk enemas are used once daily at bedtime.

  • Treatment with Salofalk enemas must be administered regularly and consistently, because only in this way can healing be successfully achieved.

  • The duration of use is determined by the physician.


Method of administration:


Rectal use.


The best results are achieved if the bowel is emptied before administration of the Salofalk enema.


Preparation:



  • The bottle should be shaken for 30 seconds.

  • Then the protective cap of the applicator is removed.

  • The bottle should be held at the top and bottom.


The correct position for administration is as follows:



  • The patient should lie down on his/her left side with his/her left leg stretched out and right leg bent.

  • This makes it easier for the rectal suspension to be administered and for the enema to be effective.


Administration of the rectal suspension:



  • The tip of the applicator should be inserted deep into the rectum.

  • The bottle should be tipped downwards slightly and then squeezed slowly.

  • Once the bottle is empty, the applicator tip should be slowly withdrawn from the rectum.

  • The patient should remain lying down in this position for at least 30 minutes to allow the contents of the enema to spread throughout the rectum.

  • If possible, the rectal suspension should be allowed to exert its effects all night.


Warnings And precautions:



  • Blood tests (differential blood count; liver function parameters like ALT or AST; serum creatinine) and urinary status (dip sticks) should be determined prior to and during treatment, at the discretion of the treating physician.

  • As a guideline, follow-up tests are recommended 14 days after commencement of treatment, then a further two to three tests at intervals of 4 weeks.

  • If the findings are normal, follow-up tests should be carried out every 3 months.

  • If additional symptoms occur, these tests should be performed immediately.


Caution is recommended in patients with impaired hepatic function.



  • Salofalk enemas should not be used in patients with impaired renal function.

  • Mesalazine-induced renal toxicity should be considered, if renal function deteriorates during treatment.

  • Patients with pulmonary disease, in particular asthma, should be very carefully monitored during a course of treatment with Salofalk enemas.

  • Patients with a history of adverse drug reactions to preparations containing sulphasalazine should be kept under close medical surveillance on commencement of a course of treatment with Salofalk enemas.

  • Should Salofalk enemas cause acute intolerance reactions such as abdominal cramps, acute abdominal pain, fever, severe headache and rash, therapy should be discontinued immediately.

  • Due to their potassium metabisulphite content, Salofalk enemas can provoke allergic reactions with anaphylactic symptoms and bronchial constriction (bronchospasm) in sensitive patients, particularly in those with asthma or a history of allergies. 

  • Because the product contains sodium benzoate, it may provoke hypersensitivity reactions in suitably predisposed patients in the form of irritation of the skin, eyes and mucous membranes. 


Ingredients:



  • MESALAZINE (5-aminosalicylic acid) 4g/60ml.

Product Details:

    Prescription required to order this medicinePrescription required to order this medicine
    Upload a prescriptionUpload a prescription
    IBS & Colitis
    GIT Treatments
    Salofalk

    Salofalk 4 g/60 mL Mesalazine Enemas 7 Count

    138.05 SAR

    Salofalk 4 g/60 mL Mesalazine Enemas 7 Count
    Prescription required to order this medicinePrescription required to order this medicine
    Upload a prescriptionUpload a prescription

    Product Description:


    Salofalk 4g/60ml enemas contain the active substance mesalazine:



    • An anti-inflammatory agent used to treat inflammatory bowel disease.

    • Salofalk 4g/60ml enemas are used for the treatment of:

    • inflammation of the large intestine (colon) and rectum (back passage) known by doctors as ulcerative colitis.

    • It may be used alone or, particularly in the acute phase, with corticosteroids.

    • Acute attacks of ulcerative colitis (a chronic inflammatory disease of the large bowel)


    How To Use:


    Adults and elderly:



    • In patients with symptoms of acute inflammation, the content of one enema bottle (60 g rectal suspension) is administered into the intestine as a clyster once daily at bedtime.


     Children and adolescents:



    • There is little experience and only limited documentation for an effect in children.


    General instructions for use:



    • Salofalk enemas are used once daily at bedtime.

    • Treatment with Salofalk enemas must be administered regularly and consistently, because only in this way can healing be successfully achieved.

    • The duration of use is determined by the physician.


    Method of administration:


    Rectal use.


    The best results are achieved if the bowel is emptied before administration of the Salofalk enema.


    Preparation:



    • The bottle should be shaken for 30 seconds.

    • Then the protective cap of the applicator is removed.

    • The bottle should be held at the top and bottom.


    The correct position for administration is as follows:



    • The patient should lie down on his/her left side with his/her left leg stretched out and right leg bent.

    • This makes it easier for the rectal suspension to be administered and for the enema to be effective.


    Administration of the rectal suspension:



    • The tip of the applicator should be inserted deep into the rectum.

    • The bottle should be tipped downwards slightly and then squeezed slowly.

    • Once the bottle is empty, the applicator tip should be slowly withdrawn from the rectum.

    • The patient should remain lying down in this position for at least 30 minutes to allow the contents of the enema to spread throughout the rectum.

    • If possible, the rectal suspension should be allowed to exert its effects all night.


    Warnings And precautions:



    • Blood tests (differential blood count; liver function parameters like ALT or AST; serum creatinine) and urinary status (dip sticks) should be determined prior to and during treatment, at the discretion of the treating physician.

    • As a guideline, follow-up tests are recommended 14 days after commencement of treatment, then a further two to three tests at intervals of 4 weeks.

    • If the findings are normal, follow-up tests should be carried out every 3 months.

    • If additional symptoms occur, these tests should be performed immediately.


    Caution is recommended in patients with impaired hepatic function.



    • Salofalk enemas should not be used in patients with impaired renal function.

    • Mesalazine-induced renal toxicity should be considered, if renal function deteriorates during treatment.

    • Patients with pulmonary disease, in particular asthma, should be very carefully monitored during a course of treatment with Salofalk enemas.

    • Patients with a history of adverse drug reactions to preparations containing sulphasalazine should be kept under close medical surveillance on commencement of a course of treatment with Salofalk enemas.

    • Should Salofalk enemas cause acute intolerance reactions such as abdominal cramps, acute abdominal pain, fever, severe headache and rash, therapy should be discontinued immediately.

    • Due to their potassium metabisulphite content, Salofalk enemas can provoke allergic reactions with anaphylactic symptoms and bronchial constriction (bronchospasm) in sensitive patients, particularly in those with asthma or a history of allergies. 

    • Because the product contains sodium benzoate, it may provoke hypersensitivity reactions in suitably predisposed patients in the form of irritation of the skin, eyes and mucous membranes. 


    Ingredients:



    • MESALAZINE (5-aminosalicylic acid) 4g/60ml.

    Product Details:

      • Genuine  brands

        Genuine brands


      • Temperature Controlled

        Temperature Controlled


      • Secure Payment

        Secure Payment

      Salofalk 4 g/60 mL Mesalazine Enemas 7 Count